Access the full text.
Sign up today, get DeepDyve free for 14 days.
(1996)Proc Natl Acad Sci
J. Herman, J. Graff, S. Myöhänen, B. Nelkin, S. Baylin (1996)Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Proceedings of the National Academy of Sciences of the United States of America, 93 18
K. Yamashita, T. Dai, Yuichi Dai, F. Yamamoto, M. Perucho (2003)Genetics supersedes epigenetics in colon cancer phenotype.
Cancer cell, 4 2
N. Hawkins, R. Ward (2001)Sporadic colorectal cancers with microsatellite instability and their possible origin in hyperplastic polyps and serrated adenomas.
Journal of the National Cancer Institute, 93 17
T. Gaiser, Sandra Meinhardt, D. Hirsch, J. Killian, J. Gaedcke, Peter Jo, I. Ponsa, R. Miró, J. Rüschoff, G. Seitz, Yue Hu, J. Camps, T. Ried (2013)Molecular patterns in the evolution of serrated lesion of the colorectum
International Journal of Cancer, 132
W. Samowitz, C. Sweeney, Jennifer Herrick, H. Albertsen, T. Levin, M. Murtaugh, R. Wolff, M. Slattery (2005)Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers.
Cancer research, 65 14
J. Carethers, E. Smith, Cynthia Behling, L. Nguyen, A. Tajima, Ryan Doctolero, B. Cabrera, A. Goel, Christian Arnold, K. Miyai, C. Boland (2004)Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer.
Gastroenterology, 126 2
C. Arnold, A. Goel, C. Compton, V. Marcus, D. Niedzwiecki, J. Dowell, L. Wasserman, Toru Inoue, R. Mayer, M. Bertagnolli, C. Boland, C. Boland (2004)Evaluation of Microsatellite Instability, hMLH1 Expression and hMLH1 Promoter Hypermethylation in Defining the MSI Phenotype of Colorectal Cancer
Cancer Biology & Therapy, 3
S. Ogino, T. Kawasaki, G. Kirkner, P. Kraft, M. Loda, C. Fuchs (2007)Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
The Journal of molecular diagnostics : JMD, 9 3
A. Roth, S. Tejpar, M. Delorenzi, P. Yan, R. Fiocca, D. Klingbiel, D. Dietrich, B. Biesmans, G. Bodoky, C. Barone, E. Aranda, B. Nordlinger, L. Cisar, R. Labianca, D. Cunningham, E. Cutsem, F. Bosman (2010)Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 28 3
K. Matsuzaki, G. Deng, Hirofumi Tanaka, S. Kakar, S. Miura, Y. Kim (2005)The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer
Clinical Cancer Research, 11
N. Hawkins, M. Norrie, K. Cheong, E. Mokany, S. Ku, A. Meagher, T. O'Connor, R. Ward (2002)CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability.
Gastroenterology, 122 5
M. Rijnsoever, F. Grieu, H. Elsaleh, David Joseph, B. Iacopetta (2002)Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands
A. Goel, C. Boland (2012)Epigenetics of colorectal cancer.
Gastroenterology, 143 6
George (2000)Classification of advanced colorectal carcinomas by tumor edge morphology: evidence for different pathogenesis and significance of polypoid and nonpolypoid tumors
R. Jover, T. Nguyen, Lucía Pérez-Carbonell, P. Zapater, A. Payá, C. Alenda, E. Rojas, J. Cubiella, F. Balaguer, F. Balaguer, J. Morillas, J. Clofent, L. Bujanda, J. Reñé, X. Bessa, Rosa Xicola, D. Pérez, A. Castells, M. Andreu, X. Llor, C. Boland, A. Goel (2011)5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer.
Gastroenterology, 140 4
Shen (2002)Epigenetics in colorectal cancer
Curr Opin Gastroenterol, 18
J. Ahn, W. Chung, O. Maeda, S. Shin, Hyun Kim, Hyun Chung, N. Kim, J. Issa (2011)DNA methylation predicts recurrence from resected stage III proximal colon cancer
D. Weisenberger, K. Siegmund, Mihaela Campan, Joanne Young, T. Long, M. Faasse, G. Kang, M. Widschwendter, D. Weener, D. Buchanan, H. Koh, L. Simms, M. Barker, B. Leggett, J. Levine, Myungjin Kim, A. French, S. Thibodeau, J. Jass, R. Haile, P. Laird (2006)CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer
Nature Genetics, 38
J. Jass (2007)Classification of colorectal cancer based on correlation of clinical, morphological and molecular features
K. CurtinTitle: Comprehensive Profiling of Dna Methylation in Colorectal Cancer Reveals Subgroups with Distinct Clinicopathological and Molecular Features
Eri Arai, S. Chiku, Taisuke Mori, Masahiro Gotoh, T. Nakagawa, Hiroyuki Fujimoto, Y. Kanai (2012)Single-CpG-resolution methylome analysis identifies clinicopathologically aggressive CpG island methylator phenotype clear cell renal cell carcinomas
Susannah George, M. Mäkinen, P. Jernvall, J. Mäkelä, P. Vihko, T. Karttunen (2000)Classification of advanced colorectal carcinomas by tumor edge morphology
S. Popat, R. Hubner, R. Houlston (2005)Systematic review of microsatellite instability and colorectal cancer prognosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 23 3
Lanlan Shen, P. Catalano, A. Benson, P. O'dwyer, S. Hamilton, J. Issa (2007)Association between DNA Methylation and Shortened Survival in Patients with Advanced Colorectal Cancer Treated with 5-Fluorouracil–Based Chemotherapy
Clinical Cancer Research, 13
Lanlan Shen, M. Toyota, Y. Kondo, E. Lin, Li Zhang, Yi Guo, N. Hernandez, Xinli Chen, Saira Ahmed, K. Konishi, S. Hamilton, J. Issa (2007)Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer
Proceedings of the National Academy of Sciences, 104
W. Samowitz, H. Albertsen, Jennifer Herrick, T. Levin, C. Sweeney, M. Murtaugh, R. Wolff, M. Slattery (2005)Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer.
Gastroenterology, 129 3
B. Iacopetta, K. Kawakami, Toshiaki Watanabe (2008)Predicting clinical outcome of 5-fluorouracil-based chemotherapy for colon cancer patients: is the CpG island methylator phenotype the 5-fluorouracilresponsive subgroup?
International Journal of Clinical Oncology, 13
A. Goel, T. Nagasaka, C. Arnold, Toru Inoue, C. Hamilton, D. Niedzwiecki, C. Compton, R. Mayer, R. Goldberg, M. Bertagnolli, C. Boland (2007)The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.
Gastroenterology, 132 1
M. Toyota, N. Ahuja, Mutsumi Ohe-Toyota, J. Herman, S. Baylin, J. Issa (1999)CpG island methylator phenotype in colorectal cancer.
Proceedings of the National Academy of Sciences of the United States of America, 96 15
B. Iacopetta, F. Grieu, W. Li, A. Ruszkiewicz, M. Caruso, J. Moore, G. Watanabe, K. Kawakami (2006)APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer
International Journal of Cancer, 119
Lei He, Konstandinos Vasiliou, D. Nebert (2009)Analysis and update of the human solute carrier (SLC) gene superfamily
Human Genomics, 3
Ying Huang, W. Sadee (2006)Membrane transporters and channels in chemoresistance and -sensitivity of tumor cells.
Cancer letters, 239 2
A. Chan, J. Issa, Jeffrey Morris, S. Hamilton, A. Rashid (2002)Concordant CpG island methylation in hyperplastic polyposis.
The American journal of pathology, 160 2
S. Ogino, K. Nosho, G. Kirkner, T. Kawasaki, A. Chan, E. Schernhammer, E. Giovannucci, C. Fuchs (2008)A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer.
Journal of the National Cancer Institute, 100 23
M. Rijnsoever, H. Elsaleh, D. Joseph, K. McCaul, B. Iacopetta (2003)CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 9 8
Hui Li, L. Myeroff, D. Smiraglia, M. Romero, T. Pretlow, L. Kasturi, J. Lutterbaugh, R. Rerko, G. Casey, J. Issa, J. Willis, J. Willson, C. Plass, S. Markowitz (2003)SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers
Proceedings of the National Academy of Sciences of the United States of America, 100
Seun-Ja Park, A. Rashid, Jaehyuk Lee, S. Kim, S. Hamilton, Tsung-Teh Wu (2003)Frequent CpG island methylation in serrated adenomas of the colorectum.
The American journal of pathology, 162 3
L. Barault, C. Charon-Barra, V. Jooste, Mathilde Vega, Laurent Martin, P. Roignot, P. Rat, A. Bouvier, P. Laurent-Puig, J. Faivre, C. Chapusot, F. Piard (2008)Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases.
Cancer research, 68 20
A. Etcheverry, M. Aubry, M. Tayrac, E. Vauléon, Rachel Boniface, Frédérique Guénot, S. Saikali, A. Hamlat, L. Riffaud, P. Menei, V. Quillien, J. Mosser (2010)DNA methylation in glioblastoma: impact on gene expression and clinical outcome
BMC Genomics, 11
F. Sinicrope, N. Foster, S. Thibodeau, S. Marsoni, G. Monges, R. Labianca, George Kim, G. Yothers, C. Allegra, M. Moore, S. Gallinger, D. Sargent (2011)DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
Journal of the National Cancer Institute, 103 11
Park (2003)Frequent CpG island methylation in serrated adenomas of the colorectum
Am J Pathol, 162
T. Ueki, M. Toyota, H. Skinner, K. Walter, C. Yeo, J. Issa, R. Hruban, M. Goggins (2001)Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma.
Cancer research, 61 23
Joanne Young, J. Jass (2006)The Case for a Genetic Predisposition to Serrated Neoplasia in the Colorectum: Hypothesis and Review of the Literature
Cancer Epidemiology Biomarkers & Prevention, 15
C. Ribic, D. Sargent, M. Moore, S. Thibodeau, A. French, R. Goldberg, S. Hamilton, P. Laurent-Puig, R. Gryfe, L. Shepherd, D. Tu, M. Redston, S. Gallinger (2003)Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer.
The New England journal of medicine, 349 3
S. Derks, C. Postma, B. Carvalho, S. Bosch, P. Moerkerk, J. Herman, M. Weijenberg, A. Bruïne, G. Meijer, M. Engeland (2008)Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
Carcinogenesis, 29 2
S. Ogino, K. Nosho, G. Kirkner, T. Kawasaki, J. Meyerhardt, M. Loda, E. Giovannucci, C. Fuchs (2008)CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
G. Hutchins, K. Southward, K. Handley, L. Magill, C. Beaumont, J. Stahlschmidt, S. Richman, P. Chambers, M. Seymour, D. Kerr, R. Gray, P. Quirke (2011)Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 29 10
Jairo Rodríguez, J. Frigola, E. Vendrell, R. Risques, M. Fraga, C. Morales, V. Moreno, M. Esteller, G. Capellá, M. Ribas, M. Peinado (2006)Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.
Cancer research, 66 17
A subset of colorectal cancers (CRCs) harbor the CpG island methylator phenotype (CIMP), with concurrent multiple promoter hypermethylation of tumor‑related genes. A serrated pathway in which CIMP is developed from serrated polyps is proposed. The present study characterized CIMP and morphologically examined precursor lesions of CIMP. In total, 104 CRCs treated between January 1996 and December 2004 were examined. Aberrant promoter methylation of 15 cancer‑related genes was analyzed. CIMP status was classified according to the number of methylated genes and was correlated with the clinicopathological features, including the concomitant polyps in and around the tumors. The frequency of aberrant methylation in each CRC showed a bimodal pattern, and the CRCs were classified as CIMP‑high (CIMP‑H), CIMP‑low (CIMP‑L) and CIMP‑negative (CIMP‑N). CIMP‑H was associated with aberrant methylation of MLH1 (P=0.005) and with an improved recurrence‑free survival (RFS) rate following curative resection compared with CIMP‑L/N (five‑year RFS rate, 93.8 vs. 67.1%; P=0.044), while CIMP‑N tumors were associated with frequent distant metastases at diagnosis (P=0.023). No concomitant serrated lesions were present in the tumors, whereas conventional adenoma was contiguous with 11 (10.6%) of 104 CRCs, including four CIMP‑H CRCs. CIMP‑H was classified in CRCs by a novel CIMP marker panel and the presence of concomitant tumors revealed that certain CIMP‑H CRCs may have arisen from conventional adenomas.
Oncology Letters – Spandidos Publications
Published: Nov 1, 2014
Access the full text.
Sign up today, get DeepDyve free for 14 days.